New products are live, and we’ve lowered prices across the catalog. Heads up - high demand means a 2–3 day shipping backlog. Free shipping on orders over $200!
Palm Beach Vitality

Tirzepatide 50mg Vial

$200.00

Tirzepatide 5 mL Vial

The Science, Simplified: Tirzepatide is a synthetic dual agonist peptide studied as a GIP and GLP-1 receptor pathway research tool in laboratory and preclinical models.

Product Specifications – Tirzepatide 5 mL Vial (50 mg)

  • Total Tirzepatide: 50 mg
  • Volume: 5 mL vial
  • Concentration: 10 mg/mL
  • Purity: ≥99%, third-party tested (COA available)
  • Format: Ready-to-use liquid vial

Key Research Focus: Used for dual incretin-receptor assays that examine concurrent GIP and GLP-1 signaling at a straightforward 10 mg/mL liquid concentration.

Physical Form & Solubility:

  • Appearance: Clear to slightly opalescent liquid
  • Solubility: Already in aqueous solution. Highly soluble; no reconstitution required.

Stability & Handling Notes:

  • Refrigerated at 36-46°F. Practical shelf life is 16-20 weeks when protected from light and handled with clean laboratory technique.
  • Do not freeze. Avoid prolonged room-temperature exposure.
  • Discard after 20 weeks or if the solution becomes cloudy, discolored, or shows particulate matter.
  • Protect from light and moisture at all times.
  • For lyophilized orders please contact us (minimum order required)
    https://www.palmbeach-vitality.com

Tirzepatide 50 mg / 5 mL (10 mg/mL) research vial from Palm Beach Vitality. Third-party tested with COA. Laboratory research use only.

How Labs Use This Format: Labs pipette from this sealed 5 mL ready-to-use liquid vial at 10 mg/mL for dual GIP/GLP-1 receptor pathway work. Tirzepatide pen formats may be available in the metabolic pens category.

Documentation Trail: Third-party testing and lot-matched COA from Palm Beach Vitality support laboratory procurement records for this 50 mg Tirzepatide vial. Cold-pack shipping on qualifying orders.

Research Use Only

For laboratory research use only (RUO). Not for human use, veterinary use, household use, or consumption. Not a drug, food, supplement, or cosmetic. Not intended to diagnose, treat, cure, or prevent any disease. Buyer represents they are a qualified researcher purchasing for lawful research purposes only.

Image coming soon. Dual GIP/GLP-1 receptor agonist research vial in a 50 mg / 5 mL liquid fill. Distinct from the Retatrutide multi-receptor line; COA with every lot.

Tirzepatide Research Studies

Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.

Read the Tirzepatide research overview

  1. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 DiabetesPubMed 34170647
  2. Tirzepatide Once Weekly for the Treatment of ObesityPubMed 35658024
  3. Tirzepatide for Obesity Treatment and Diabetes PreventionPubMed 39536238
  4. Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity ManagementPubMed 36750526
  5. Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development programPubMed 36478180
Tirzepatide amino acid chain
Tirzepatide — amino acid chain (N→C)